FENNEC PHARMACEUTICALS INC. (FENC) › Operating IncomeFENNEC PHARMACEUTICALS INC. (FENC) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2010: -$4.60M2011: -$3.44M2012: -$3.62M2013: -$1.93M2014: -$2.88M2015: -$1.89M2016: -$2.87M2017: -$6.95M2018: -$10.41M2019: -$13.01M2020: -$17.89M2021: -$17.22M2022: -$22.59M2023: -$12.77M2024: $2.57M2025: -$6.28M-$6.28M2010Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$6.28M-344.6%2024$2.57M+120.1%2023-$12.77M+43.5%2022-$22.59M-31.2%2021-$17.22M+3.7%2020-$17.89M-37.5%2019-$13.01M-25.0%2018-$10.41M-49.7%2017-$6.95M-142.1%2016-$2.87M-51.9%2015-$1.89M+34.3%2014-$2.88M-49.0%2013-$1.93M+46.7%2012-$3.62M-5.3%2011-$3.44M+25.3%2010-$4.60M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share